Harvard Infectious Diseases in Adults 2025

Description

+ Include: 59 videos + 53 pdfs, size: 35.2 GB

+ Target Audience: infectious diseases physicians, internists, hospitalists, family physicians, pulmonologists, critical care physicians, emergency medicine physicians

+ Information:

State-of-the-Art Approaches to Prevention, Diagnosis, and Treatment of Infectious Diseases

Infectious Diseases in Adults 2025 will be held online this year, using live streaming technology and live question and answer sessions. 

OVERVIEW

This comprehensive CME program ensures attendees are current with state-of-the-art approaches to prevention, diagnosis, and treatment of infectious diseases. Updates, best practices, and new guidelines are presented by nationally recognized ID experts and master clinicians. Education is practical and results-driven:

• Optimal decision-making in the prevention, diagnosis, and treatment of infectious diseases
• Newer antimicrobials and treatment strategies for highly resistant infections
• Prevention and treatment of infections in immunocompromised hosts
• Update on antifungal diagnostics and therapy
• State-of-the-art and multidisciplinary approaches to common infections
• Clinical approaches to complex, rare, and “don’t-miss” infections
• New, evolving, emerging, and re-emerging infectious diseases
• Infections in persons with substance use disorder
• What’s new in HIV prevention and management
• The latest on COVID-19, including long COVID

As revised treatment strategies, new diagnostic tests, and guidelines are presented, they are coupled with specific recommendations for incorporating these updates into your day-to-day work.
Highlights of the 2025 Program

Expanded Case-Based and Problem-Solving Education 

The 2025 program features an expanded range of interactive, case-based, and problem-solving education. The formats are engaging, and attendees are encouraged to pose questions to our national experts in live question-and-answer sessions following the lectures and the multidisciplinary workshops. Our speakers and panelists include not only ID experts, but those from fields such as pharmacy, surgery, radiology, cardiology, pulmonology, and addiction medicine, thereby providing a 360-degree context for the understanding of ID treatment and patient care. Our ten multidisciplinary workshops include complicated urinary tract and intra-abdominal infections, native and prosthetic valve endocarditis, musculoskeletal infections, and nontuberculous mycobacterial infections.

Treating Highly Resistant Infections, including:

• MRSA and VISA (vancomycin-intermediate Staph aureus)
• Extended-spectrum beta-lactamase (ESBL)-producing Gram-negative rods
• Carbapenemase-producing Gram-negative rods, including NDM-1 metallo-beta-lactamase-producing organisms
• Vancomycin-resistant enterococci (VRE)
• Aspergillus and non-aspergillus mold infections
• Candida auris
• Nontuberculous mycobacteria (NTM)

Common Infectious Diseases: Updates in Prevention, Diagnosis, and Treatment

Updates to keep you current on new strategies, state-of-the-art practices, and the most recent guidelines to address:

• Respiratory viral infections, including COVID-19
• New and updated vaccines
• Infections in the expanding populations of immunocompromised hosts
• Infections in persons with substance use disorder
• Infections of travelers and foreign-born persons
• Systemic fungal infections
• Native and device-related orthopedic infections
• Central nervous system (CNS) infections
• Ear, nose, and throat (ENT) and eye infections
• Skin and soft tissue infections
• Bronchiectasis and pneumonia
• HIV and its infectious and noninfectious complications
• PEP (Post-Exposure Prophylaxis) and PrEP (Pre-Exposure Prophylaxis) to prevent HIV infection
• Sexually transmitted infections (STIs), including mpox and PEP for prevention of STIs
• Hepatitis B and C infections
• Tick- and mosquito-borne infections
• Clostridioides difficile infection
• Complicated urinary tract infections
• Intra-abdominal infections

Challenging, Rare, and Emerging Infectious Diseases

Comprehensive updates on:

• Rare and emerging infectious diseases, including highly pathogenic avian flu and Marburg virus
• Re-emergence of vaccine-preventable diseases, including poliomyelitis
• Pulmonary and extrapulmonary non-tuberculous (“atypical”) mycobacteria, including Mycobacterium abscessus
• Global infectious diseases of clinical importance

Clinical Decision-Making

Hear directly from world-renowned specialists and master clinicians on their approach and decision-making criteria for:

• Selecting the best antimicrobial and duration of treatment
• Rapid detection and empiric treatment of life-threatening infectious diseases
• Choosing between inpatient and outpatient treatment, and between intravenous and oral antimicrobials
• Optimizing empiric antimicrobial therapy: what to start, and when to narrow or stop

Our multidisciplinary talks and workshops incorporate safety, quality, and practice improvement in infectious diseases, including:

• Antimicrobial stewardship to prevent resistance and reduce cost
• Infection control to reduce transmission in health care settings
• Early inpatient ID consultations to improve outcomes
• Strategies for management of infection in persons who inject drugs (PWID)

Optimized for Remote Education

The 2025 program has been enhanced for distance learning. In addition to being live streamed, all session recordings will be made available to participants for online viewing for 90 days after the end of the course.

+ Topics:

1. Schedule.pdf
2. Uyeki Plenary will not be recorded (please read).pdf
3. CPC Embargo (please read).pdf
Day 1 An Antibiotic Allergy Toolkit.mp4
Day 1 An Antibiotic Allergy Toolkit.pdf
Day 1 Antimicrobial Stewardship.mp4
Day 1 Antimicrobial Stewardship.pdf
Day 1 Clostridioides difficile Infection, Including Recurrent and Refractory Disease and Novel Approaches.mp4
Day 1 Clostridioides difficile Infection, Including Recurrent and Refractory Disease and Novel Approaches.pdf
Day 1 Infection Control 101 for the ID Clinician.mp4
Day 1 Infection Control 101 for the ID Clinician.pdf
Day 1 Introduction and Road Map Infectious Diseases of Adults.mp4
Day 1 Introduction and Road Map Infectious Diseases of Adults.pdf
Day 1 Live Q & A 1.mp4
Day 1 Live Q & A 2.mp4
Day 1 Live Q & A 3.mp4
Day 1 Live Q & A 4.mp4
Day 1 Panel Workshop #1 Resistant Gram-Positive Infections.mp4
Day 1 Panel Workshop #1 Resistant Gram-Positive Infections.pdf
Day 1 Panel Workshop #2 Resistant Gram-Negative Infections.mp4
Day 1 Panel Workshop #2 Resistant Gram-Negative Infections.pdf
Day 1 Plenary Highly Pathogenic Avian Influenza Uyeki Plenary will not be recorded (please read).pdf
Day 1 Principles of Antimicrobial Therapy.mp4
Day 1 Principles of Antimicrobial Therapy.pdf
Day 1 Skin and Soft Tissue Infections.mp4
Day 1 Skin and Soft Tissue Infections.pdf
Day 1 Update on Antifungal Diagnostics and Therapy.mp4
Day 1 Update on Antifungal Diagnostics and Therapy.pdf
Day 2 Bone and Joint Infections A Conceptual Framework.mp4
Day 2 Bone and Joint Infections A Conceptual Framework.pdf
Day 2 Encephalitis and Meningitis The Newest Guidelines and Best.mp4
Day 2 Encephalitis and Meningitis The Newest Guidelines and Best.pdf
Day 2 Keynote Lecture-Protecting Public Health with Vaccines Understanding Our Past, Protecting Our Future.mp4
Day 2 Keynote Lecture-Protecting Public Health with Vaccines Understanding Our Past, Protecting Our Future.pdf
Day 2 Live Q & A 1.mp4
Day 2 Live Q & A 2.mp4
Day 2 Live Q & A 3.mp4
Day 2 New and Emerging Viruses.mp4
Day 2 New and Emerging Viruses.pdf
Day 2 Panel Workshop #3 Native Bone Infections.mp4
Day 2 Panel Workshop #3 Native Bone Infections.pdf
Day 2 Panel Workshop #4 Orthopedic Device Infections Prosthetic Joint Infections.mp4
Day 2 Panel Workshop #4 Orthopedic Device Infections Prosthetic Joint Infections.pdf
Day 2 Staphylococcus aureus D‚j… Vu All Over Again.mp4
Day 2 Staphylococcus aureus D‚j… Vu All Over Again.pdf
Day 2 State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections.mp4
Day 2 State-of-the-Art Diagnosis and Management of Sexually Transmitted Infections.pdf
Day 2 Tick Talk Lyme Disease, Ehrlichia, Anaplasma, Babesia, Rickettsia, and Other Tick-Borne Infections.mp4
Day 2 Tick Talk Lyme Disease, Ehrlichia, Anaplasma, Babesia, Rickettsia, and Other Tick-Borne Infections.pdf
Day 3 Advances in Viral Hepatitis HBV and HCV.mp4
Day 3 Advances in Viral Hepatitis HBV and HCV.pdf
Day 3 Critical Care ID.mp4
Day 3 Critical Care ID.pdf
Day 3 Endocarditis and Cardiac Device Infections.mp4
Day 3 Endocarditis and Cardiac Device Infections.pdf
Day 3 Live Q & A 1.mp4
Day 3 Live Q & A 2.mp4
Day 3 Live Q & A 3.mp4
Day 3 Live Q & A 4.mp4
Day 3 Panel Workshop #5 Multidisciplinary Management of Intraabdominal Infections (Including New Guidelines).mp4
Day 3 Panel Workshop #5 Multidisciplinary Management of Intraabdominal Infections (Including New Guidelines).pdf
Day 3 Panel Workshop #6 Challenges in Native Valve Endocarditis (Including in Persons with Substance Use Disorder).mp4
Day 3 Panel Workshop #6 Challenges in Native Valve Endocarditis (Including in Persons with Substance Use Disorder).pdf
Day 3 Panel Workshop #7 Multidisciplinary Management of Prosthetic Valve Endocarditis (Including in Persons with Substance Use Disorder).mp4
Day 3 Panel Workshop #7 Multidisciplinary Management of Prosthetic Valve Endocarditis (Including in Persons with Substance Use Disorder).pdf
Day 3 Panel Workshop #8 Multidisciplinary Management of Complex Urinary Tract Infections.mp4
Day 3 Panel Workshop #8 Multidisciplinary Management of Complex Urinary Tract Infections.pdf
Day 3 The Syndemic of SUD and Infection Updated Approaches for 2025.mp4
Day 3 The Syndemic of SUD and Infection Updated Approaches for 2025.pdf
Day 4 Cellular and Immune-Based Therapies for Cancer 2025 What the ID Clinician Needs to Know.mp4
Day 4 Cellular and Immune-Based Therapies for Cancer 2025 What the ID Clinician Needs to Know.pdf
Day 4 Flummoxing Cases in Fungal Infections.mp4
Day 4 Flummoxing Cases in Fungal Infections.pdf
Day 4 Infections in Hematologic Malignancies and Stem Cell Transplantation.mp4
Day 4 Infections in Hematologic Malignancies and Stem Cell Transplantation.pdf
Day 4 Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy.mp4
Day 4 Infections Related to Solid Organ Transplant and Non-Oncologic Immunomodulatory Therapy.pdf
Day 4 Live Q & A 1.mp4
Day 4 Live Q & A 2.mp4
Day 4 Live Q & A 3.mp4
Day 4 Navigating New Vaccines Updates and Recommendations.mp4
Day 4 Navigating New Vaccines Updates and Recommendations.pdf
Day 4 Pre- and Post-Exposure Prophylaxis for HIV and STIs.mp4
Day 4 Pre- and Post-Exposure Prophylaxis for HIV and STIs.pdf
Day 4 Understanding and Addressing the Continuing Challenges in HIVAssociated Opportunistic Infections.mp4
Day 4 Understanding and Addressing the Continuing Challenges in HIVAssociated Opportunistic Infections.pdf
Day 4 Updates on COVID-19, Including Long COVID-19.mp4
Day 4 Updates on COVID-19, Including Long COVID-19.pdf
Day 4 What’s New in the Care of People with HIV in 2025.mp4
Day 4 What’s New in the Care of People with HIV in 2025.pdf
Day 5 Bronchiectasis, Pneumonia, and NTM Infections Anatomic and Clinical Approaches.mp4
Day 5 Bronchiectasis, Pneumonia, and NTM Infections Anatomic and Clinical Approaches.pdf
Day 5 Cases in Global Infectious Diseases.mp4
Day 5 Cases in Global Infectious Diseases.pdf
Day 5 Eye and ENT Infections What You Need to Know in 2025.mp4
Day 5 Eye and ENT Infections What You Need to Know in 2025.pdf
Day 5 Full Live.mp4
Day 5 Kim – Viral Hepatitis.pdf
Day 5 Live New England Journal of Medicine Clinicopathologic Conference (CPC) NEJM CPC Embargo (please read).pdf
Day 5 Live New England Journal of Medicine Clinicopathologic Conference (CPC) NEJM CPC Presentation of Case – audience only.pdf
Day 5 Panel Workshop #10 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Extrapulmonary.mp4
Day 5 Panel Workshop #10 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Extrapulmonary.pdf
Day 5 Panel Workshop #9 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Pulmonary.mp4
Day 5 Panel Workshop #9 Management of Complex Nontuberculous Mycobacterial (NTM) Infection Pulmonary.pdf
Day 5 The Latest on Major Respiratory Viral Infections.mp4
Day 5 The Latest on Major Respiratory Viral Infections.pdf
Day 5 Tropical Medicine 2025 Review and Update.mp4
Day 5 Tropical Medicine 2025 Review and Update.pdf
Day 5 Tuberculosis Update.mp4
Day 5 Tuberculosis Update.pdf
Harvard CME _ Infectious Diseases in Adults.pdf
NEJM CPC Embargo Notice.pdf